Evidence map›Paper›PMID 12368252›Full record

ArticleGenome research2002

An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islands.

Zunyan Dai, Dieter Weichenhan, Yue-Zhong Wu, Julia L Hall, Laura J Rush, Laura T Smith, Aparna Raval, Li Yu, Daniela Kroll, Joerg Muehlisch and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Zunyan DaiDivision of Human Cancer Genetics, Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA.
Dieter Weichenhan
Yue-Zhong Wu
Julia L Hall
Laura J Rush
Laura T Smith
Aparna Raval
Li Yu
Daniela Kroll
Joerg Muehlisch
Michael C Frühwald
Pieter de Jong
Joe Catanese
Ramana V Davuluri
Dominic J Smiraglia
Christoph Plass
The Ohio State University · USUniversity of Lübeck · DEUniversity of Münster · DECancer Genetics (United States) · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
ONOCOLOGY TRAINING GRANTT32CA009338 · NCI · OHIO STATE UNIVERSITY · PI BYRD, JOHN C., POLLOCK, RAPHAEL E. · 1985 to 2018
$8.3M
GENOMIC SCANNING IN ORAL CANCERR01DE013123 · NIDCR · OHIO STATE UNIVERSITY · PI PLASS, CHRISTOPH · 2000 to 2011
$2.3M
DNA methylation as a diagnostic marker in AMLR01CA093548 · NCI · OHIO STATE UNIVERSITY · PI PLASS, CHRISTOPH · 2002 to 2006
$1.5M
Aberrant DNA Methylation in Acute Myeloid LeukemiaK08CA089317 · NCI · OHIO STATE UNIVERSITY · PI RUSH, LAURA J · 2002 to 2006
$576k
NCI NIH HHS CA089317NCI NIH HHS K08 CA089317NCI NIH HHS P30 CA016058NCI NIH HHS P30 CA16058NCI NIH HHS R01 CA093548NCI NIH HHS R01 CA93548NCI NIH HHS T32 CA009338NCI NIH HHS T32 CA09338NIDCR NIH HHS R01 DE013123NIDCR NIH HHS R01 DE13123
6 · The paper itself

Abstract

Knudson's two-hit hypothesis postulates that genetic alterations in both alleles are required for the inactivation of tumor-suppressor genes. Genetic alterations include small or large deletions and mutations. Over the past years, it has become clear that epigenetic alterations such as DNA methylation are additional mechanisms for gene silencing. Restriction Landmark Genomic Scanning (RLGS) is a two-dimensional gel electrophoresis that assesses the methylation status of thousands of CpG islands. RLGS has been applied successfully to scan cancer genomes for aberrant DNA methylation patterns. So far, the majority of this work was done using NotI as the restriction landmark site. Here, we describe the development of RLGS using AscI as the restriction landmark site for genome-wide scans of cancer genomes. The availability of AscI as a restriction landmark for RLGS allows for scanning almost twice as many CpG islands in the human genome compared with using NotI only. We describe the development of an AscI-EcoRV boundary library that supports the cloning of novel methylated genes. Feasibility of this system is shown in three tumor types, medulloblastomas, lung cancers, and head and neck cancers. We report the cloning of 178 AscI RLGS fragments via two methods by use of this library.

Indexed as

Deoxyribonucleases, Type II Site-SpecificDNA MethylationGene LibraryGenome, HumanCloning, MolecularCpG IslandsDNA FragmentationElectrophoresis, Gel, Two-DimensionalGene Expression Regulation, NeoplasticGenes, NeoplasmHumansRestriction MappingDeoxyribonucleases, Type II Site-Specificendodeoxyribonuclease AscIGATATC-specific type II deoxyribonucleasesGCGGCCGC-specific type II deoxyribonucleases

Identifiers

PMID12368252
PMCPMC187524
OpenAlexW2120211296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.